Logo image of TF7A.DE

TYSON FOODS INC-CL A (TF7A.DE) Stock Fundamental Analysis

FRA:TF7A - Deutsche Boerse Ag - US9024941034 - Common Stock - Currency: EUR

44.32  +1.77 (+4.17%)

Fundamental Rating

3

Taking everything into account, TF7A scores 3 out of 10 in our fundamental rating. TF7A was compared to 57 industry peers in the Food Products industry. Both the profitability and financial health of TF7A have multiple concerns. TF7A is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year TF7A was profitable.
TF7A had a positive operating cash flow in the past year.
TF7A had positive earnings in 4 of the past 5 years.
TF7A had a positive operating cash flow in each of the past 5 years.
TF7A.DE Yearly Net Income VS EBIT VS OCF VS FCFTF7A.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B

1.2 Ratios

TF7A has a worse Return On Assets (-1.79%) than 78.33% of its industry peers.
Looking at the Return On Equity, with a value of -3.57%, TF7A is doing worse than 78.33% of the companies in the same industry.
With a Return On Invested Capital value of 2.01%, TF7A is not doing good in the industry: 68.33% of the companies in the same industry are doing better.
TF7A had an Average Return On Invested Capital over the past 3 years of 9.12%. This is above the industry average of 6.98%.
The last Return On Invested Capital (2.01%) for TF7A is well below the 3 year average (9.12%), which needs to be investigated, but indicates that TF7A had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.79%
ROE -3.57%
ROIC 2.01%
ROA(3y)5.13%
ROA(5y)5.48%
ROE(3y)10.02%
ROE(5y)11.55%
ROIC(3y)9.12%
ROIC(5y)8.96%
TF7A.DE Yearly ROA, ROE, ROICTF7A.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

TF7A's Operating Margin of 1.47% is on the low side compared to the rest of the industry. TF7A is outperformed by 70.00% of its industry peers.
TF7A's Operating Margin has declined in the last couple of years.
TF7A's Gross Margin of 5.54% is on the low side compared to the rest of the industry. TF7A is outperformed by 93.33% of its industry peers.
In the last couple of years the Gross Margin of TF7A has declined.
Industry RankSector Rank
OM 1.47%
PM (TTM) N/A
GM 5.54%
OM growth 3Y-44.06%
OM growth 5Y-27.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.01%
GM growth 5Y-15.34%
TF7A.DE Yearly Profit, Operating, Gross MarginsTF7A.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so TF7A is still creating some value.
Compared to 1 year ago, TF7A has less shares outstanding
Compared to 5 years ago, TF7A has more shares outstanding
TF7A has a worse debt/assets ratio than last year.
TF7A.DE Yearly Shares OutstandingTF7A.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
TF7A.DE Yearly Total Debt VS Total AssetsTF7A.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.89 indicates that TF7A is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of TF7A (2.89) is better than 76.67% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that TF7A is not too dependend on debt financing.
TF7A's Debt to Equity ratio of 0.45 is fine compared to the rest of the industry. TF7A outperforms 61.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 2.89
ROIC/WACC0.29
WACC6.95%
TF7A.DE Yearly LT Debt VS Equity VS FCFTF7A.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

TF7A has a Current Ratio of 1.34. This is a normal value and indicates that TF7A is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.34, TF7A is in line with its industry, outperforming 45.00% of the companies in the same industry.
TF7A has a Quick Ratio of 1.34. This is a bad value and indicates that TF7A is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of TF7A (0.52) is worse than 81.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 0.52
TF7A.DE Yearly Current Assets VS Current LiabilitesTF7A.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

3

3. Growth

3.1 Past

TF7A shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -84.77%.
TF7A shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -26.40% yearly.
The Revenue has decreased by -0.75% in the past year.
TF7A shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.71% yearly.
EPS 1Y (TTM)-84.77%
EPS 3Y-38.72%
EPS 5Y-26.4%
EPS Q2Q%-77.3%
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y6.98%
Revenue growth 5Y5.71%
Sales Q2Q%-2.83%

3.2 Future

TF7A is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.44% yearly.
TF7A is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.44% yearly.
EPS Next Y129.2%
EPS Next 2Y71.93%
EPS Next 3Y71.69%
EPS Next 5Y51.44%
Revenue Next Year2.21%
Revenue Next 2Y1.97%
Revenue Next 3Y2.85%
Revenue Next 5Y2.44%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TF7A.DE Yearly Revenue VS EstimatesTF7A.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B
TF7A.DE Yearly EPS VS EstimatesTF7A.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

TF7A is valuated quite expensively with a Price/Earnings ratio of 36.33.
Based on the Price/Earnings ratio, TF7A is valued a bit more expensive than 68.33% of the companies in the same industry.
TF7A is valuated rather expensively when we compare the Price/Earnings ratio to 27.48, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.81 indicates a correct valuation of TF7A.
Based on the Price/Forward Earnings ratio, TF7A is valued a bit more expensive than 63.33% of the companies in the same industry.
TF7A's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.52.
Industry RankSector Rank
PE 36.33
Fwd PE 15.81
TF7A.DE Price Earnings VS Forward Price EarningsTF7A.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

TF7A's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. TF7A is more expensive than 68.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.03
TF7A.DE Per share dataTF7A.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

TF7A's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TF7A's earnings are expected to grow with 71.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y71.93%
EPS Next 3Y71.69%

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.18%, TF7A is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.34, TF7A pays a bit more dividend than its industry peers.
TF7A's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

The dividend of TF7A has a limited annual growth rate of 5.22%.
Dividend Growth(5Y)5.22%
Div Incr Years0
Div Non Decr Years0
TF7A.DE Yearly Dividends per shareTF7A.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 0.5 1 1.5

5.3 Sustainability

TF7A has negative earnings and hence a negative payout ratio. The dividend may be in danger.
TF7A's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-103.4%
EPS Next 2Y71.93%
EPS Next 3Y71.69%
TF7A.DE Yearly Income VS Free CF VS DividendTF7A.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

More info and screens

TYSON FOODS INC-CL A

FRA:TF7A (11/24/2023, 7:00:00 PM)

44.32

+1.77 (+4.17%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.74B
Analysts55.79
Price Target48.01 (8.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend1.87
Dividend Growth(5Y)5.22%
DP-103.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.28%
Min EPS beat(2)-42.88%
Max EPS beat(2)26.32%
EPS beat(4)1
Avg EPS beat(4)-39.63%
Min EPS beat(4)-104.96%
Max EPS beat(4)26.32%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.93%
Min Revenue beat(2)-4.27%
Max Revenue beat(2)-3.58%
Revenue beat(4)0
Avg Revenue beat(4)-3.82%
Min Revenue beat(4)-4.52%
Max Revenue beat(4)-2.91%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.85%
PT rev (3m)-8.24%
EPS NQ rev (1m)-44.87%
EPS NQ rev (3m)-57.16%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.8%
Revenue NQ rev (1m)-0.67%
Revenue NQ rev (3m)-1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.87%
Valuation
Industry RankSector Rank
PE 36.33
Fwd PE 15.81
P/S 0.32
P/FCF N/A
P/OCF 9.77
P/B 0.94
P/tB 7.94
EV/EBITDA 12.03
EPS(TTM)1.22
EY2.75%
EPS(NY)2.8
Fwd EY6.32%
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)4.54
OCFY10.23%
SpS136.88
BVpS46.94
TBVpS5.58
PEG (NY)0.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.79%
ROE -3.57%
ROCE 2.61%
ROIC 2.01%
ROICexc 2.04%
ROICexgc 4.41%
OM 1.47%
PM (TTM) N/A
GM 5.54%
FCFM N/A
ROA(3y)5.13%
ROA(5y)5.48%
ROE(3y)10.02%
ROE(5y)11.55%
ROIC(3y)9.12%
ROIC(5y)8.96%
ROICexc(3y)9.7%
ROICexc(5y)9.42%
ROICexgc(3y)23.7%
ROICexgc(5y)24.19%
ROCE(3y)11.67%
ROCE(5y)11.45%
ROICexcg growth 3Y-44.29%
ROICexcg growth 5Y-32.9%
ROICexc growth 3Y-40.81%
ROICexc growth 5Y-27.15%
OM growth 3Y-44.06%
OM growth 5Y-27.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.01%
GM growth 5Y-15.34%
F-Score5
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 3.88
Cap/Depr 144.81%
Cap/Sales 3.67%
Interest Coverage 2.29
Cash Conversion 82.8%
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 0.52
Altman-Z 2.89
F-Score5
WACC6.95%
ROIC/WACC0.29
Cap/Depr(3y)133.79%
Cap/Depr(5y)123.33%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-84.77%
EPS 3Y-38.72%
EPS 5Y-26.4%
EPS Q2Q%-77.3%
EPS Next Y129.2%
EPS Next 2Y71.93%
EPS Next 3Y71.69%
EPS Next 5Y51.44%
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y6.98%
Revenue growth 5Y5.71%
Sales Q2Q%-2.83%
Revenue Next Year2.21%
Revenue Next 2Y1.97%
Revenue Next 3Y2.85%
Revenue Next 5Y2.44%
EBIT growth 1Y-82.38%
EBIT growth 3Y-40.15%
EBIT growth 5Y-23.82%
EBIT Next Year236.89%
EBIT Next 3Y78.35%
EBIT Next 5Y46.33%
FCF growth 1Y-123.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.8%
OCF growth 3Y-23.24%
OCF growth 5Y-9.98%